Perfomedil

This classification denotes a vasodilating agent with the molecular formula C19H29NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8A8NY1Z12E, chemically known as 4-(3-methyl-1-piperidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone but generally known as perfomedil, which bears US NIH Compound Identifier 65831. European Medicines Agency schedules Perfomedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09723MIG. The term PERFOMEDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). PERFOMEDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule perfomedil under HS 29333999 and SITC 51574. As of Q4 2014, PERFOMEDIL remains the US FDA Preferred Term for this commodity. Perfomedil bears US NLM identifiers UMLS ID C1882329 and NCI Concept Code C66355. SMILES: O=C(CCCN1CC(CCC1)C)c1c(OC)cc(OC)cc1OC.